Literature DB >> 11801288

Role of CRF(1) and CRF(2) receptors in fear and anxiety.

L K Takahashi1.   

Abstract

Fear and anxiety are common emotions that can be triggered by stress. This paper reviews the work examining the role played by specific corticotropin-releasing factor (CRF) receptors in mediating the expression of these emotions. Several lines of evidence taken from CRF(1) transgenic knockout mice, CRF(1) antisense oligonucleotide studies, and CRF(1) receptor antagonist work suggest that the anxiety inducing effects of CRF are mediated by the CRF(1) receptor. Of these three methodological approaches, the work using transgenic CRF(1) knockout mice appears to be the most consistent. In contrast, the work using specific CRF(1) antagonists has produced somewhat varied results that may be explained, in part, by the testing method. When animals are stressed prior to behavioral testing, CRF(1) receptor antagonists appear to have anxiolytic-like effects. In addition, chronic dosing with CRF(1) antagonists may have more potent anxiolytic-like effects, especially in animal models of spontaneous anxiety, than acute dosing procedures. Spontaneous anxiety is defined as behavior that is elicited entirely by the testing situation without current or prior aversive or explicitly induced stress. CRF(1) antisense oligonucleotide work is difficult to interpret because of potential toxicological side effects produced by the antisense oligonucleotide and, in some cases, the absence of verifiable reductions in CRF(1) receptor densities after treatment. Similar methods-CRF(2) knockouts, CRF(2) antisense oligonucleotides, and CRF(2) antagonists-were used to evaluate the function of CRF(2) receptors in emotionality. In comparison to the large number of CRF(1) receptor studies, fewer CRF(2) receptor investigations have been conducted and these studies have yielded mixed results. However, recent work demonstrating a robust reduction in CRF(2) receptors using a CRF(2) antisense oligonucleotide with minimal toxicity, and dose response studies using a peptide CRF(2) antagonist suggest that CRF(2) receptors play a role in stress-induced and spontaneous anxiety. Furthermore, inhibiting the actions of both CRF(1) and CRF(2) receptors produces a greater reduction in stress-induced behavior than inhibition of either receptor alone. Thus, current data suggest that CRF(1) and CRF(2) receptors are involved in the mediation of fear and anxiety behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11801288     DOI: 10.1016/s0149-7634(01)00046-x

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  47 in total

1.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

2.  Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.

Authors:  Lisa H Conti
Journal:  Neuropharmacology       Date:  2011-08-02       Impact factor: 5.250

3.  Behavioral inhibition and glucocorticoid dynamics in a rodent model.

Authors:  Sonia A Cavigelli; Michele M Stine; Colleen Kovacsics; Akilah Jefferson; Mai N Diep; Catherine E Barrett
Journal:  Physiol Behav       Date:  2007-07-03

4.  Formation of behavioral pathology in female C57BL/6J mice exposed to prolonged negative psychoemotional conditions.

Authors:  D F Avgustinovich; I L Kovalenko
Journal:  Neurosci Behav Physiol       Date:  2005-11

5.  Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.

Authors:  Catherine S Hubbard; Jennifer S Labus; Joshua Bueller; Jean Stains; Brandall Suyenobu; George E Dukes; Dennis L Kelleher; Kirsten Tillisch; Bruce D Naliboff; Emeran A Mayer
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

6.  A novel genotyping method for detection of the CRHR1 (rs1396862: C>T) gene variation among North Indian population.

Authors:  Neeraj Sharma; Shally Awasthi; Subha R Phadke
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

Review 7.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

8.  Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear.

Authors:  D T Hubbard; B R Nakashima; I Lee; L K Takahashi
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

9.  Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.

Authors:  Shawn M Vuong; Harvey A Oliver; Jamie L Scholl; Kathryn M Oliver; Gina L Forster
Journal:  Behav Brain Res       Date:  2009-12-01       Impact factor: 3.332

10.  Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity.

Authors:  Russ E Carpenter; Michael J Watt; Gina L Forster; Øyvind Øverli; Craig Bockholt; Kenneth J Renner; Cliff H Summers
Journal:  Horm Behav       Date:  2007-08-08       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.